APA

Hashimoto R., Fujiwara H., Higashihashi N., Enjoh-Kimura T., Terasawa H., Fujita-Yamaguchi Y., Inagaki F., Perdue J. F. & Sakano K. (19950905). N-terminal deletion mutants of insulin-like growth factor-II (IGF-II) show Thr7 and Leu8 important for binding to insulin and IGF-I receptors and Leu8 critical for all IGF-II functions. : The Journal of biological chemistry.

Chicago

Hashimoto R, Fujiwara H, Higashihashi N, Enjoh-Kimura T, Terasawa H, Fujita-Yamaguchi Y, Inagaki F, Perdue J F and Sakano K. 19950905. N-terminal deletion mutants of insulin-like growth factor-II (IGF-II) show Thr7 and Leu8 important for binding to insulin and IGF-I receptors and Leu8 critical for all IGF-II functions. : The Journal of biological chemistry.

Harvard

Hashimoto R., Fujiwara H., Higashihashi N., Enjoh-Kimura T., Terasawa H., Fujita-Yamaguchi Y., Inagaki F., Perdue J. F. and Sakano K. (19950905). N-terminal deletion mutants of insulin-like growth factor-II (IGF-II) show Thr7 and Leu8 important for binding to insulin and IGF-I receptors and Leu8 critical for all IGF-II functions. : The Journal of biological chemistry.

MLA

Hashimoto R, Fujiwara H, Higashihashi N, Enjoh-Kimura T, Terasawa H, Fujita-Yamaguchi Y, Inagaki F, Perdue J F and Sakano K. N-terminal deletion mutants of insulin-like growth factor-II (IGF-II) show Thr7 and Leu8 important for binding to insulin and IGF-I receptors and Leu8 critical for all IGF-II functions. : The Journal of biological chemistry. 19950905.